DealZone

Deals wrap: Getting hostile

October 4, 2010

A sign points the way to the headquarters of Genzyme in Cambridge, Massachusetts August 3, 2010.  REUTERS/Brian Snyder   Sanofi is getting hostile in its bid for Genzyme, after Genzyme management refused to negotiate. The $69-per-share offer will be taken directly to shareholders but will they be looking for more? *View article *View graphic on hostile dealsĀ  *View WSJ article on pharma M&A

Growth in emerging markets is aiding a global M&A boom and with large cash piles in hand, companies are finding it hard to resist the urge to acquire. *View article

Coca-Cola has completed its deal to take over North American operation of its top bottler, Coca-Cola Enterprises. Reuters interviewed Coke Chief Executive Muhtar Kent about what the deal will mean for the remaining independent bottlers. *View article

Business Insider makes the case for Yahoo and AOL merging, immediately. *View Business Insider article

Post Your Comment

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/